The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment

The development of cancer causes disruption of anti-tumor immunity required for surveillance and elimination of tumor cells. Immunotherapeutic strategies aim for the restoration or establishment of these anti-tumor immune responses. Cancer immunotherapies include immune checkpoint inhibitors (ICIs),...

Descripción completa

Detalles Bibliográficos
Autores principales: Uche, Ifeanyi Kingsley, Kousoulas, Konstantin G., Rider, Paul J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310320/
https://www.ncbi.nlm.nih.gov/pubmed/34206677
http://dx.doi.org/10.3390/v13071200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310320/
https://www.ncbi.nlm.nih.gov/pubmed/34206677
http://dx.doi.org/10.3390/v13071200

Ejemplares similares